Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Smith Scott ThomasEVP & CFO | Ascendis Pharma A/SASND | Open-market buy | 06/02 | 06/02 | 100 sh | $219.00 | $21,900 | +2.3% |
Ascendis Pharma A/SASND | Open-market buy | 05/29 | 06/01 | 500 sh3 trades | $223.12avg. | $111,562 | +125.0% | |
Smith Scott ThomasEVP & CFO | Ascendis Pharma A/SASND | Open-market buy | 05/29 | 06/01 | 250 sh | $223.32 | $55,830 | +6.2% |
Ascendis Pharma A/SASND | Open-market buy | 05/26 | 05/27 | 400 sh2 trades | $237.81avg. | $95,122 | No record | |
Jensen Flemming SteenSEE REMARKS | Ascendis Pharma A/SASND | Open-market sale | 05/11 | 05/12 | 19,460 sh | $238.49 | $4,641,015.4 | −100.0% |